Smith Hunter C sold RYTM
August 13, 2025 · Form 4 insider transaction
Smith Hunter C sold 3,477 shares of Rhythm Pharmaceuticals, Inc. at $96.00 per share, a transaction worth $333.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,477
Price
$96.00
Total value
$333.8K
InsiderSmith Hunter C
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 14, 2025
Shares owned after116,915
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.